Hydroxychloroquine Retinopathy in Inflammatory Arthritis: A Retrospective Analysis in Canadian Patients

被引：0
|
作者：
Osman, Mohammed [1 ]
Burnett, Heather [1 ]
Kydd, Alison [2 ]
Davis, Paul [1 ]
Rudnisky, Christopher [1 ]
Tennant, Matthew [1 ]
Yacyshyn, Elaine [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2067
引用
收藏
页码：S806 / S806
页数：1
相关论文
共 50 条
  • [31] Correspondence on "assessing the risk of retinopathy in Indian patients using hydroxychloroquine for rheumatic and musculoskeletal diseases: A retrospective observational study"
    Dadhaniya, Nikunjkumar V.
    Upadhyaya, Sundeep
    Gupta, Sirinder J.
    Handa, Rohini
    INDIAN JOURNAL OF RHEUMATOLOGY, 2021, 16 (03) : 367 - 368
  • [32] Comment on: Assessing the risk of retinopathy in indian patients using hydroxychloroquine for rheumatic and musculoskeletal diseases: A retrospective observational study
    Manoj, Manesh
    Sahoo, Rasmi Ranjan
    Wakhlu, Anupam
    INDIAN JOURNAL OF RHEUMATOLOGY, 2021, 16 (03) : 365 - 366
  • [33] Assessing the risk of retinopathy in indian patients using hydroxychloroquine for rheumatic and musculoskeletal diseases: A retrospective observational study - Reply
    Roy, Arindam
    Samala, Vinitha
    Kumar, Yarram
    Fatima, Syeda
    INDIAN JOURNAL OF RHEUMATOLOGY, 2022, 17 (02) : 204 - 205
  • [34] Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis
    Andres Cordova Sanchez
    Farzam Khokhar
    Danielle A. Olonoff
    Robert L. Carhart
    Cardiovascular Drugs and Therapy, 2024, 38 : 297 - 304
  • [35] Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis
    Wasko, Mary Chester M.
    Hubert, Helen B.
    Lingala, Vijaya Bharathi
    Elliott, Jennifer R.
    Luggen, Michael E.
    Fries, James F.
    Ward, Michael M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (02): : 187 - 193
  • [36] Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis
    Carmichael, SJ
    Charles, B
    Tett, SE
    THERAPEUTIC DRUG MONITORING, 2003, 25 (06) : 671 - 681
  • [37] Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis
    Sanchez, Andres Cordova
    Khokhar, Farzam
    Olonoff, Danielle A.
    Carhart, Robert L.
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (02) : 297 - 304
  • [38] Inflammatory Arthritis in Patients with Myelodysplastic Syndrome: French Multicenter Retrospective Study
    Mekinian, Arsene
    Decaux, Olivier
    Falgarone, Geraldine
    Braun, Thorsten, Sr.
    Toussirot, Eric
    Raffray, Loic
    Gombert, Bruno
    de Wazieres, Bruno
    Buchdaul, Anne Laure
    Ziza, Jean-Marc
    Launay, David
    Denis, Guillaume
    Madaule, Serge
    Fenaux, Pierre
    Fain, Olivier
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S83 - S84
  • [39] Possible Association of Early Inflammatory Arthritis with Viral Outbreaks Such As Influenza: Time Series Analysis of the Canadian Early Inflammatory Arthritis Cohort
    Kudaeva, Fatima
    Speechley, Mark
    Klar, Neil
    Schieir, Orit
    Bartlett, Susan J.
    Bessette, Louis
    Boire, Gilles
    Hazlewood, Glen
    Hitchon, Carol A.
    Keystone, Edward C.
    Tin, Diane
    Thorne, Carter
    Bykerk, Vivian P.
    Pope, Janet E.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [40] Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis
    Becciolini, Andrea
    Parisi, Simone
    Caccavale, Rosalba
    Bravi, Elena
    Lumetti, Federica
    Andracco, Romina
    Volpe, Alessandro
    Gardelli, Lucia
    Girelli, Francesco
    Di Donato, Eleonora
    Santilli, Daniele
    Lucchini, Gianluca
    Ditto, Maria Chiara
    Plate, Ilaria
    Arrigoni, Eugenio
    Mozzani, Flavio
    Riva, Michele
    Marchetta, Antonio
    Fusaro, Enrico
    Sandri, Gilda
    Salvarani, Carlo
    Paroli, Marino
    Ariani, Alarico
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (03):
12345